Latest Financial Turnaround News

FlexiRoam has reported its second consecutive quarter of positive operating cash flow and returned to a positive net current asset position for the first time in over eight years, underpinned by record underlying EBITDA and strategic AI partnerships.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.

Atomos Limited has reported a robust Q2 FY26 with a 44% jump in revenue and its second straight EBITDA-positive quarter, signaling a promising turnaround. The company’s strategic product launches and debt reduction efforts underpin an optimistic outlook for the second half of the fiscal year.

Structural Monitoring Systems Plc reports a profitable December quarter with 40% revenue growth, driven by strong avionics sales and progress toward FAA certification of its CVM™ technology.

Phoslock Environmental Technologies has reversed its cashflow deficits with a quarterly surplus, resumed factory operations after a long pause, and is gearing up for significant sales growth in 2026.

Wellnex Life reports a $2.4 million EBITDA improvement in H1 FY26 and reaches breakeven by Q2, supported by strong Pain Away sales and expanded distribution.

Openn Negotiation Limited has reported a return to profitability for the year ended 30 June 2025, posting a total comprehensive profit of $412,860. The company will hold its Annual General Meeting in January 2026, with no dividends proposed.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

Elsight has transitioned from development to production with its new Aura communications platform, delivering initial units to a leading defence contractor and expanding its U.S. presence amid a strong financial turnaround in 2025.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

Cann Group Limited has announced a dramatic 81% reduction in core debt alongside a strategic pivot to higher-margin flower products, positioning the company for its first EBITDA-positive year in FY26.